The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers

Alec J. Kacew, Allison C. Grimes, Michael Roth, Deanna Teoh, Wendy Landier, Garth W. Strohbehn, Electra D. Paskett

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)518-519
Number of pages2
JournalCA Cancer Journal for Clinicians
Volume70
Issue number6
DOIs
StatePublished - Nov 1 2020

Bibliographical note

Funding Information:
Alec J. Kacew has received research support from the Pritzker School of Medicine and the American Society of Hematology for work performed outside of the current study. Allison C. Grimes has received grants from the Cancer Prevention Research Institute of Texas for work performed outside of the current study. Deanna Teoh has received grants from Acelity and salary support for her role as a local principal investigator for an industry‐sponsored trial from GlaxoSmithKline for work performed outside of the current study. Wendy Landier has received grants from the National Cancer Institute of the National Institutes of Health and nonfinancial support to her institution from Merck, Sharp & Dohme for work performed outside of the current study. Garth W. Strohbehn's institution has received fellowship funding support from Abbott Laboratories Inc and he holds a filed provisional patent not applicable to the current study. Electra D. Paskett has received grants from the National Cancer Institute of the National Institutes of Health for work performed as part of the current study and has received grants from the Merck Foundation, Pfizer, the Breast Cancer Research Foundation, Foxconn, and the One Family Foundation for work performed outside of the current study. Michael Roth made no disclosures.

Cite this